Showing results (1051-1060 of 6,005) with videos related to

Sort By:
Pageof 601
Molecular Psychiatry|March 27, 2023
Altered behavior, brain structure, and neurometabolites in a rat model of autism-specific maternal autoantibody exposureMatthew R Bruce, Amalie C M Couch, Simone Grant, et al.
Molecular Psychiatry|May 30, 2020
Allosteric modulation of AMPA receptors counteracts Tau-related excitotoxic synaptic signaling and memory deficits in stress- and Aβ-evoked hippocampal pathologyDaniela Monteiro-Fernandes, Joana Margarida Silva, Carina Soares-Cunha, et al.
Molecular Psychiatry|May 18, 2021
Kidins220 deficiency causes ventriculomegaly via SNX27-retromer-dependent AQP4 degradationAna Del Puerto, Julia Pose-Utrilla, Ana Simón-García, et al.
Molecular Psychiatry|May 18, 2021
Environmental exposures associated with elevated risk for autism spectrum disorder may augment the burden of deleterious de novo mutations among probandsKealan Pugsley, Stephen W Scherer, Mark A Bellgrove, et al.
Molecular Psychiatry|June 4, 2020
Chronic administration of ketamine induces cognitive deterioration by restraining synaptic signalingYayan Luo, Yang Yu, Minling Zhang, et al.
Molecular Psychiatry|June 4, 2020
Clozapine modulates retinoid homeostasis in human brain and normalizes serum retinoic acid deficit in patients with schizophreniaFrancesca Regen, Nicoleta-Carmen Cosma, Lisa R Otto, et al.
Molecular Psychiatry|June 26, 2020
Amyloid, tau, and astrocyte pathology in autosomal-dominant Alzheimer's disease variants: AβPParc and PSEN1DE9Laetitia Lemoine, Per-Göran Gillberg, Nenad Bogdanovic, et al.
Molecular Psychiatry|May 23, 2020
AP-1 controls the p11-dependent antidepressant responseRevathy U Chottekalapanda, Salina Kalik, Jodi Gresack, et al.
Molecular Psychiatry|August 7, 2021
Cerebrospinal fluid flow cytometry distinguishes psychosis spectrum disorders from differential diagnosesSaskia Räuber, Michael Heming, Jonathan Repple, et al.
Molecular Psychiatry|August 11, 2021
Binding of SEP-363856 within TAAR1 and the 5HT1A receptor: implications for the design of novel antipsychotic drugsPramod C Nair, John O Miners, Ross A McKinnon, et al.
Pageof 601